Inhibitory effects of pharmacological doses of dexamethasone on mineralization of mesenchymal progenitor cells in vitro

Pharmazie

Volumn 64, Issue 10, 2009, Pages 674-679

  Shao, Jin ^a   Xu, Xiangyang ^a   Li, Guosong ^a   Zhang, Wei ^a   Qi, Jin ^a   Wang, Jinshen ^a   Cai, Ming ^a   Cui, Lun ^a   Zhang, Lianfang ^a   Zhao, Qiang ^a   Deng, Lianfu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; BETA ACTIN; BROXURIDINE; DEXAMETHASONE; LIPOCORTIN 5; MESSENGER RNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; ANTIINFLAMMATORY AGENT; COLORING AGENT; OSTERIX PROTEIN, MOUSE; RUNX2 PROTEIN, MOUSE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; CALVARIA; CELL COUNT; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; VON KOSSA STAINING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, WESTERN; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CELL PROLIFERATION; COLORING AGENTS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TRANSCRIPTION FACTORS;

EID: 74949089754     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.9561     Document Type: Article

References (27)

1. Avram D, Ranta F, Hennige AM, Berchtold S, Hopp S, Häring HU, Lang F, Ullrich S (2008) IGF-1 protects against dexamethasone-induced cell death in insulin secreting INS-1 cells independent of AKT/PKB phosphorylation. Cell Physiol Biochem 21: 455-462.
2. Buranasinsup S, Sila-Asna M, Bunyaratvej N, Bunyaratvej A (2006) In vitro osteogenesis from human skin-derived precursor cells. Dev Growth Differ 48: 263-269.
3. Canalis E (2005) Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 3: 98-102.
4. Chen TL (2004) Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 35: 83-95.
5. Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8: 739-750.
6. Eijken M, Koedam M, vanDriel M, Buurman CJ, Pols HA, van Leeuwen JP (2006) The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248: 87-93.
7. Haasper C, Drescher M, Hesse E, Krettek C, Zeichen J, Jagodzinski M (2008) Osteogenic differentiation of human bone marrow stromal cells (hBMSC) by cyclic longitudinal mechanical strain and dexamethasone. Z Orthop Unfall 146: 636-643.
8. Hayashi K, Yamaguchi T, Yano S, Kanazawa I, Yamauchi M, Yamamoto M, Sugimoto T (2009) BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 379: 261-266.
9. Hong D, Chen HX, Ge RS, Li JC (2008) The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells. J Steroid Biochem Mol Bio 111: 164-170.
10. Igarashi M, Kamiya N, Hasegawa M, Kasuya T, Takahashi T, Takagi M (2004) Inductive effects of dexamethasone on the gene expression of Cbfa1, osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol 35: 3-10.
11. Ishida Y, Heersche JN (1998) Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 13: 1822-1826.
12. Ito S, Suzuki N, Kato S, Takahashi T, Takagi M (2007) Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40: 84-92.
13. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
14. Lafage-Proust MH, Boudignon B, Thomas T (2003) Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments. Joint Bone Spine 70: 109-118.
15. Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG, Smith E, Frenkel B (2004) Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 33: 175-193.
16. Li X, Jin L, Cui Q, Wang GJ, Balian G (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16: 101-108.
17. Macrae VE, Ahmed SF, Mushtaq T, Farquharson C (2007) IGF-I signalling in bone growth: inhibitory actions of dexamethasone and IL-1beta. Growth Horm IGF Res 17: 435-439.
18. Mikami Y, Omoteyama K, Kato S, Takagi M (2007) Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Biochem Biophys Res Commun 362: 368-373.
19. Mikami Y, Takahashi T, Kato S, Takagi M (2008) Dexamethasone promotes DMP1 mRNA expression by inhibiting negative regulation of Runx2 in multipotential mesenchymal progenitor, ROB-C26. Cell Biol Int 32: 239-246.
20. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H (1999) Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2112-2118.
21. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
22. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
23. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ (1981) Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108: 213-219.
24. Pereira RC, Delany AM, Canalis E (2002) Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT enhancer binding protein expression. Bone 30: 685-691.
25. Pereira RM, Delany AM, Canalis E (2001) Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone 28: 484-490.
26. Scutt A, Bertram P, Brautigam M (1996) The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects. Calcif Tissue Int 59: 154-162.
27. Sivagurunathan S, Muir MM, Brennan TC, Seale JP, Mason RS (2005) Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res 20: 390-398.